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Abstract
Insufﬁcient vitamin D status (serum 25-hydroxyvitamin D (S-25(OH)D)< 50 nmol/l) is common among immigrants living at the northern
latitudes. We investigated ethnic differences in response of S-25(OH)D to vitamin D3 supplementation, through a 5-month randomised
controlled trial, in East African and Finnish women in Southern Finland (60°N) from December 2014 to May 2015. Vitamin D intakes (dietary
and supplemental) were also examined. Altogether, 191 subjects were screened and 147 women (East Africans n 72, Finns n 75) aged 21–64
years were randomised to receive placebo or 10 or 20 µg of vitamin D3/d. S-25(OH)D concentrations were assessed by liquid
chromatography–tandem MS. At screening, 56% of East Africans and 9% of Finns had S-25(OH)D< 50 nmol/l. Total vitamin D intake was
higher in East Africans than in Finns (24·2 (SD 14·3) v. 15·2 (SD 13·4) µg/d, P< 0·001). Baseline mean S-25(OH)D concentrations were higher in
Finns (60·5 (SD= 16·3) nmol/l) than in East Africans (51·5 (SD 15·4) nmol/l) (P= 0·001). In repeated-measures ANCOVA (adjusted for baseline
S-25(OH)D), mean S-25(OH)D increased by 8·5 and 10·0 nmol/l with a 10-µg dose and by 10·7 and 17·1 nmol/l with a 20-µg dose for Finns and
East Africans, respectively (P> 0·05 for differences between ethnic groups). In conclusion, high prevalence of vitamin D insufﬁciency existed
among East African women living in Finland, despite higher vitamin D intake than their Finnish peers. Moderate vitamin D3 supplementation
was effective in increasing S-25(OH)D in both groups of women, and no ethnic differences existed in the response to supplementation.
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Serum 25-hydroxyvitamin D (S-25(OH)D) concentration is the
most useful marker of vitamin D status(1). Sufﬁcient vitamin D
status (S-25(OH)D> 50 nmol/l) is essential for bone health,
especially in the prevention of secondary hyperparathyroidism,
which causes osteoporosis and fractures, and in reducing risk of
falls(1,2). Vitamin D insufﬁciency (S-25(OH)D< 50 nmol/l),
which has also been associated with risk for many types of
cancer and other chronic diseases(2,3), is a public health pro-
blem, affecting populations living at northern latitudes, espe-
cially during winter(4,5). Nevertheless, the situation is not always
the same between indigenous populations and immigrants.
Vitamin D status in the majority of the native populations seems
to be more satisfactory than among immigrants in the Nordic
countries(6,7).
Diet, namely fatty ﬁsh, fortiﬁed dairy products, fortiﬁed fat
spreads and cod liver oil, and vitamin D supplements remain
the main sources of vitamin D for the northern populations
during the winter months, when sun-induced vitamin D
synthesis in the skin is limited(7–10). Unlike the indigenous
populations, infrequent consumption of fatty ﬁsh and use of
vitamin D supplements has been reported among immigrants of
non-Western origin living in the Nordic countries(7,11). Hence,
in contrast to the case with indigenous populations, nutritional
factors may contribute to the high prevalence of vitamin D
deﬁciency observed among immigrants in the Nordic countries,
especially among women(11).
In particular, higher risk of vitamin D deﬁciency (S-25(OH)D<
30 nmol/l) among immigrants of African and Asian background
residing in northern countries has been reported in several
studies(6,8,12,13). Studies on skin colour and vitamin D synthesis
have observed lower vitamin D status in individuals with
dark skin than in those with lighter skin; skin pigmentation
(melanin) interferes with vitamin D synthesis from UV-B (UVB)
exposure(14,15). Wearing concealing clothing also contributes to
an increased risk of vitamin D deﬁciency(4,7). In Finland, high
prevalence of S-25(OH)D< 30 and S-25(OH)D< 50 nmol/l
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; IOM, Institute of Medicine; S-Ca, serum calcium; S-PTH, serum parathyroid hormone; S-Pi, serum phosphorus.
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was observed in two recent studies of Somali(5,12) and
Kurdish immigrants(5). In contrast to the immigrants, sufﬁcient
vitamin D status was reported for the majority of Finnish
adults in 2012(10). Insufﬁcient S-25(OH)D concentrations
have also been observed in other studies examining immigrants
of East African(16–18) and other ethnic origin(8,16,19) in the
Nordic countries.
Despite these disparities in vitamin D status between the
dark-skinned and fair-skinned populations, similar vitamin D
recommendations based on studies among Caucasian popula-
tions are currently followed among both groups in the United
States and in the Nordic countries(1,2). However, there may be
differences in vitamin D requirement and metabolism between
the different population groups(20). Concerns about the vitamin D
status and requirements of dark-skinned immigrants residing in
the Western world, the impact of ethnicity and the need for
dose–response studies were highlighted in the Institute of
Medicine (IOM) Dietary Reference Intakes report(1).
Hence, the primary objective of this 5-month randomised
controlled trial (RCT) was to investigate ethnic differences in the
response of S-25(OH)D to vitamin D3 supplementation over an
extended winter period in women of East African and Finnish
(Caucasian) descent. We also examined ethnic differences in
vitamin D status with regard to S-25(OH)D concentrations and
vitamin D intake from the diet and supplements in these two
groups of women.
Methods
Study design and subject population
This intervention study was implemented within the European
Union (EU)-funded research project ‘Food-based solutions for
optimal vitamin D nutrition and health through the life cycle’
(ODIN; FP7-613977-ODIN; www.odin-vitd.eu). Speciﬁcally, the
study was part of ODIN’s Work Package 6 with the overall
objective of delivering the proof of efﬁcacy and safety of food-
based solutions to prevent vitamin D deﬁciency by focusing on
EU-resident adults who are most at risk of vitamin D deﬁciency
owing to skin colour, sun exposure practices or dietary habits.
The study was a 5-month, randomised, placebo-controlled,
dose–response (0, 10, 20 μg/d vitamin D3) trial conducted from
December 2014 to May 2015. The study was tagged Marwo-D
(the word was coined from the Somali word ‘Marwada’, which
means lady, and the letter D, which stands for vitamin D). The
participants were recruited from the Helsinki metropolitan area
(latitude 60°N). The participants of East African descent were
recruited from the register of subjects who were shortlisted for
participation in the cross-sectional Migrant Health and Well-
being Study (Maamu), a population-based health interview and
examination survey among immigrants in Finland(21), and also
from mosques and meeting places (outside Maamu sample).
The indigenous Finnish participants were recruited from the
Health 2011 survey, a study carried out among the Finnish
mainland population(22,23), and through advertisements in
social media and on the Viikki campus area of the University of
Helsinki. Invitation letters were sent to participants from the
Maamu and Health 2011 samples, and they were subsequently
contacted by telephone. All women of East African descent
were ﬁrst-generation immigrants with Somali origin, dark-
skinned and wore traditional clothing.
A total of 191 subjects were screened for eligibility. The
inclusion criteria were female sex, Somali or Finnish origin,
BMI≤ 40 kg/m2 and S-25(OH)D concentration >30 but
<100 nmol/l. The inclusion criteria for S-25(OH)D concentra-
tion was based on ethical viewpoint (not to include deﬁcient
subjects, who need supplementation) and ability to evaluate the
response to supplementation (which may not be obvious
among participants with higher S-25(OH)D concentrations).
Exclusion criteria included pregnancy or breast-feeding during
the study, a vacation in a sunny destination before or during the
study, use of a tanning bed before or during the study and
medication or illnesses that interfere with vitamin D metabo-
lism. Medical history, S-25(OH)D concentration and other
inclusion and exclusion criteria were assessed during screening
in October/November 2014. Subjects who did not meet the
inclusion criteria owing to S-25(OH)D concentration <30 nmol/l
(i.e. vitamin D-deﬁcient) received information on dietary and
supplemental sources of vitamin D, and they were advised to
contact their healthcare services for further medical actions. In
addition, they were given either 10 or 20 µg of vitamin D3
supplements for daily use, depending on the severity of
deﬁciency. Altogether, 147 women (77% of those screened) –
72 (49%) of East African descent and 75 (51%) of Finnish
descent, aged 21–64 years – met the inclusion criteria and
were studied at the Calcium Research Unit of University of
Helsinki, Finland. Participants’ recruitment and randomisation
are presented in Fig. 1 (Consolidated Standards Of Reporting
Trials (CONSORT) diagram).
The study was conducted according to the guidelines laid
down in the Declaration of Helsinki, and all procedures invol-
ving human subjects were approved by the Coordinating Ethics
Committee of the Helsinki and Uusimaa Hospital District.
Written informed consent was obtained from all subjects. The
consent form and the participant information sheet were pro-
vided in Somali and Finnish languages. The study was regis-
tered as a clinical trial on ClinicalTrials.gov (www.ClinicalTrials.
gov; NCT02212223).
Randomisation and intervention
The East African and Finnish women who met the inclusion
criteria were randomised into three supplementation groups:
placebo or 10 or 20 µg vitamin D3/d (Fig. 1). Participants were
evenly randomised into intervention groups, for group simila-
rities with respect to the distribution of S-25(OH)D, BMI, age,
habitual vitamin D intake from supplements at screening and
ethnicity. Altogether, 125 subjects (85% of those randomised)
completed the study and twenty-two subjects (15%) dis-
continued after randomisation. The reasons for discontinuation
were as follows: withdrawal (n 8), lost to follow‐up (n 8) and
ineligible because of pregnancy (n 6). Supplements containing
10 or 20 µg of vitamin D3 per tablet and identical placebo tablets
containing 0 µg were provided by Oy Verman Ab. Supplements
and placebo tablets were kept in similar jars identiﬁable only by
the subjects’ ID numbers. Each 10-µg vitamin D3 tablet
432 F. A. Adebayo et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S000711451700397X
Downloaded from https://www.cambridge.org/core. University College Cork, on 14 Mar 2018 at 15:04:38, subject to the Cambridge Core terms of use, available at
coincides with the Finnish national recommendation for daily
vitamin D intake for the studied age group, whereas each 20-µg
tablet is twice the Finnish national recommendation for daily
vitamin D intake(24).
Each participant received a jar containing placebo or vitamin D3
tablets at the baseline visit (in December) and subsequently at
the midpoint visit (in February/March). They were advised to
take one tablet daily and were given research diaries to keep a
record of their study tablet use and occurrence of any side
effects during the intervention period. At the midpoint and
endpoint (in April/May) visits, compliance was calculated by
counting the remaining tablets in the returned jars. The parti-
cipants’ research diaries were evaluated at each visit during the
intervention.
1 
Screened for eligibility (n 191)
EA=104, FIN=87
Excluded (n 33)
S-25(OH)D <30 nmol/l (n 18)
S-25(OH)D >100 nmol/l (n 11)
BMI >40 kg/m2 (n 4)
Qualified for randomisation (n 158)
EA =82, FIN=76
Placebo
EA=28, FIN=24
Randomised into six groups (n 147)
EA =72, FIN=75
20 µg
EA=18, FIN=25
10 µg
EA=26, FIN=26
20 µg
EA=12, FIN=24
10 µg
EA=19, FIN=23
Placebo
EA=23, FIN=24
20 µg
EA=14, FIN=24
10 µg
EA=23, FIN=24
Placebo
EA=23, FIN=24
20 µg
EA=11, FIN=23
10 µg
EA=15, FIN=23
Placebo
EA=23, FIN=24
Baseline visit (n 147)
Endpoint visit (n 125)
Midpoint visit (n 132)
Completed intervention with ≥ 80 % compliance (n 119)
Placebo
EA=22, FIN=23
20 µg
EA=10, FIN=23
10 µg
EA=15, FIN=23
Included in analysis (n 116)
Ineligible – pregnancy (n 2)
Lost to follow-up (n 3)
Withdrew (n 3)
Lost to follow-up (n 2)
Ineligible – pregnancy (n 2)
Withdrew (n 2)
Lost to follow-up (n 1)
Ineligible – pregnancy (n 2)
Withdrew (n 2)
Lost to follow-up (n 1)
Withdrew (n 1)
Lost to follow-up (n 1)
Excluded (n 4)
< 80 % compliance Excluded (n 2)
< 80 % compliance
Excluded:
kidney dysfunction (n 1)
Excluded: sunburn (n 1),
pregnancy (n 1)
Ineligible – pregnancy (n 2)
Withdrew (n 5)
Lost to follow-up (n 4)
Fig. 1. Consolidated Standards Of Reporting Trials (CONSORT) diagram. Details of the recruitment, randomisation and distribution of the participants in the Marwo-D
study. EA, women of East African descent; FIN, women of Finnish descent; S-25(OH)D, serum 25-hydroxyvitamin D.
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Participants were not restricted from taking their personal
vitamin-D-containing supplements; those who used vitamin D
supplements before the study were advised to continue in the
same manner throughout the intervention period in order to
avoid changes in their habitual vitamin D intake. Participants
who had no previous personal vitamin D supplementation but
wished to start were allowed to use supplements at doses
≤10 µg of vitamin D/d. Possible changes in the use of personal
vitamin-D-containing supplements were monitored during the
intervention period.
Background and dietary data collection
Background data were collected from all participants through a
detailed questionnaire either delivered via interview (women of
East African descent) or self-administered (women of Finnish
descent). Vitamin D supplementation practices were assessed
based on how often vitamin-D-containing supplements were
used, dosage and trademark; questions on general health
included any experience of health problem and speciﬁc medi-
cation; and habitual sunshine exposure was measured by type
of clothing wore outdoors in summer, and working hours and
leisure time spent outdoors during summer. Weight and height
were measured at screening and BMI was calculated as weight
(kg)/height (m2).
Habitual vitamin D intake was assessed in all participants, on
the basis of a validated semi-quantitative interview-adminis-
tered FFQ(25), at the baseline and endpoint of the intervention.
The FFQ used in this study covered nine food groups, com-
prising altogether forty-six food items, considered important
sources of vitamin D (Table 1). Vitamin D intake during the
previous month was assessed with closed questions on con-
sumption frequencies (daily, weekly, monthly, less often or not
at all) and portion sizes (e.g. 1 glass or 1 piece). Open questions
were asked with regard to use of fat (such as spread on bread,
in cooking and baking). Information on brand name of food
products was also included in the FFQ.
Interviews with women of Finnish descent were conducted in
Finnish. Some of the women of East African descent were
interviewed entirely in the Finnish language, whereas others
were interviewed with translation by Somali-speaking research
assistants, when necessary. A picture booklet of products for-
tiﬁed with vitamin D was used to help participants identify
consumed products. Pictures showing portion sizes were also
used when needed. The questionnaire was piloted in a small East
African population (n 5) before its administration in the study.
The dietary vitamin D intakes were calculated based on the
FFQ consumption data for vitamin-D-fortiﬁed ﬂuid milk
products and fat spreads, ﬁsh and other sources (such as milk-
based foods, main courses, mushrooms and other vitamin D-
fortiﬁed products, namely cheese, bread, juice and mineral
water), using the Finnish national food composition database,
Fineli®, which was developed and is continuously updated by
the Nutrition Unit of the Finnish National Institution of Health
and Welfare (www.ﬁneli.ﬁ).
Blood sample collection
Fasting blood samples were collected at screening, baseline,
midpoint and endpoint visits, between 06.45 and 12.30 hours.
After serum separation, samples were stored frozen at −70°C
until analysis. Total S-25(OH)D concentration was assessed
from the serum samples (i.e. at screening, baseline, midpoint
and endpoint) by the Cork Centre for Vitamin D and Nutrition
Research at the University College Cork, Ireland, using liquid
chromatography-tandem MS (LC-MS/MS), which is the central
analytical platform for the ODIN project. The LC-MS/MS
method measures S-25(OH)D2 and S-25(OH)D3 separately, and
total S-25(OH)D concentrations were calculated as the sum of
these values. The inter-assay and intra-assay CV for the analyses
were <5 and <6%, respectively, for both metabolites(26). The
quality and accuracy of S-25(OH)D analysis by the LC-MS/MS in
the laboratory is guaranteed on an ongoing basis by participa-
tion in the Vitamin D External Quality Assessment Scheme
(DEQAS) (Charing Cross Hospital)(26). Moreover, the Cork
Centre for Vitamin D and Nutrition Research’s method is certi-
ﬁed under the Centers for Disease Control and Prevention
Vitamin D Standardization Certiﬁcation Program (http://www.cdc.
gov/labstandards/pdf/hs/CDC_Certiﬁed_Vitamin_D_Procedures.
pdf). In line with IOM S-25(OH)D thresholds for an adult popu-
lation, we deﬁned vitamin D status of S-25(OH)D< 30nmol/l as
deﬁcient; S-25(OH)D of 40nmol/l as concentrations that cover the
requirements of 50% of the population; S-25(OH)D 30 to
<50nmol/l as insufﬁcient; S-25(OH)D≥50nmol/l as sufﬁcient;
and sustained S-25(OH)D concentration> 125nmol/l raised
concerns about possible adverse effects(1). For study purposes,
we also deﬁned S-25(OH)D concentrations in the range of
75–125nmol/l as higher concentrations.
Serum parathyroid hormone (S-PTH) concentrations were
analysed by an immunoluminescence-based method using
Immulite1000 (Siemens Healthcare Diagnostics) at the Depart-
ment of Food and Nutrition, University of Helsinki, with inter-
assay and intra-assay CV of <8·0 and <5·5%, respectively.
Serum calcium (S-Ca), albumin and phosphorus (S-Pi) con-
centrations were assessed with a photometric method using
Konelab20 automatic analyser (Thermo Clinical Labsystems Oy)
at the Department of Food and Nutrition, University of Helsinki.
The inter-assay and intra-assay CV for S-Ca and S-Pi analyses
were <4·6 and <4·6%, respectively. S-Ca results were used as
albumin-corrected.
Statistical analysis
A power calculation based on the S-25(OH)D concentrations was
performed to estimate the number of subjects needed. On the basis
Table 1. Food groups in the FFQ
Food groups
Milk and plant-based drinks (such as soya and oat)
Yogurt, curdled milk and quark
Cheese
Milk-based foods
Main courses, meat dishes and eggs
Mushrooms
Fishes
Fat as spread on bread, in cooking and baking
Vitamin-fortified juices and mineral waters
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of the distribution of wintertime serum 25(OH)D data from our
previous study of white adult Finnish women(27), we calculated that
thirty-four volunteers per group should be recruited, with 90%
power to detect a minimum of a 10nmol/l increase in serum
25(OH)D between groups, within an ethnic group, at α=0·5.
However, this number was increased to forty for each dose group
(placebo, 10 and 20µg/d in each ethnic group) to account for
possible dropouts. A total of 240 women (120 in each ethnic
group) were aimed to be enrolled, but the targeted sample size
could not be reached because of the seasonal time frame (i.e.
wintertime) of the study. Hence, we could not extend the recruit-
ment period for more participants. We assumed that the distribu-
tion of wintertime serum 25(OH)D would be similar for non-white
adult Finnish women and used similar numbers per group.
Normality of the distribution of variables was tested with the
Kolmogorov–Smirnov test. ANOVA was used to assess differences
in normally distributed variables in intervention groups within
both ethnic groups, whereas differences in non-normally
distributed variables were evaluated with a non-parametric test
(Kruskal–Wallis). Comparison of variables between the two ethnic
groups was performed with t tests (normally distributed variables)
and the non-parametric Mann–Whitney U test (non-normally
distributed variables). Repeated-measures ANCOVA was used to
evaluate the effect of supplementation on S-25(OH)D, S-PTH, S-Ca
and S-Pi in the two ethnic groups. In ANCOVA, the baseline S-25
(OH)D, S-PTH, S-Ca or S-Pi concentration was used as a covariate.
Comparisons between intervention groups were carried out with
contrasts. Results are presented as mean values and standard
deviations, and in ﬁgures as means with their standard errors. All
results were considered statistically signiﬁcant at P<0·05. IBM
Statistical Package for the Social Sciences Statistics for Windows,
version 21.0 (IBM Corp.), was used for statistical analysis.
In the analysis focusing on the effects of intervention, three
East African subjects randomised to the group that received
20 µg/d (initial n 21) were moved to the placebo group (initial
n 25) because one of the three participants stopped the sup-
plementation after 4 d, and the other two participants did not
take the supplement at all. Final analysis included only the
participants who completed the intervention and had ≥80%
compliance rate with study supplementation in each group.
Nevertheless, three participants were excluded from the ana-
lysis for the following reasons: pregnancy (n 1), kidney dys-
function (n 1) and sunburn (n 1). Subjects on medications
owing to hypothyroidism (n 5) and type 2 diabetes (n 5) were
included in the analysis because their exclusion had no
signiﬁcant effect on the results. Altogether, data from 116
participants were analysed. Additional analyses were per-
formed for the evaluation of vitamin D status in the two ethnic
groups with regard to S-25(OH)D concentrations in all screened
subjects (n 191) and vitamin D intake from the diet and
supplements in all randomised subjects (n 147).
Results
Serum 25-hydroxyvitamin D at screening screened
We screened altogether 191 subjects (East African women
n 104, Finnish women n 87). On the basis of the IOM thresholds
for S-25(OH)D concentrations, 17% (n 18) and 39% (n 40) of
the screened East African women were deﬁcient (S-25(OH)D<
30 nmol/l) or had insufﬁcient status (S-25(OH)D 30 to
<50 nmol/l), respectively(1). There was no vitamin D deﬁciency
observed in Finnish women and the proportion of participants
who had insufﬁcient status (9%) (n 8) was lower than in East
African women. Sufﬁcient vitamin D status (S-25(OH)D≥ 50
nmol/l) was observed in 44% (n 46) of East African women
and in 91% (n 79) of Finnish women. Higher concentrations
(S-25(OH)D 75–125 nmol/l) were seen in 7% (n 7) of East
African women and 33% (n 29) of Finnish women. S-25(OH)D
concentrations above 125 nmol/l were observed in 5% (n 4) of
Finnish women (Table 2).
Characteristics of the participants in the intervention
Among the 147 randomised participants (East African women
n 72, Finnish women n 75), the mean compliance with study
supplementation in women of East African descent was 89%
(n 54) and in women of Finnish descent it was 98% (n 71). The
baseline mean S-25(OH)D concentrations were higher in
Finnish women (mean: 60·5 (SD 16·3) nmol/l) than in East
African women (mean: 51·5 (SD 15·4 ) nmol/l) (P= 0·001) (data
not shown). The characteristics of the 116 participants included
in the ﬁnal analyses are shown in Table 3. The intervention
groups in each ethnicity did not differ from one another with
regard to any background data. Nevertheless, women of East
African descent differ from Finnish women in all characteristics,
except for S-Pi concentrations.
Baseline vitamin D intake and sources of vitamin D
Total vitamin D intake at baseline, as well as that from diet and
supplements (where relevant) separately, and stratiﬁed by sup-
plement non-use and voluntary supplement use (participants
who used their personal supplements in addition to study sup-
plements) are given in Table 4. Higher mean habitual vitamin D
intakes from the diet (11·2 (SD 5·8) v. 8·4 (SD= 4·1) µg/d,
P= 0·003) and supplements (13·0 (SD 5·8) v. 6·9 (SD 4·1) µg/d,
P< 0·001) were observed in East African women (n 72) than
in Finnish participants (n 75) (Table 4). The proportions of
voluntary supplement users in East African women and
Finnish women were 88% (n 63) and 47% (n 35), respectively.
Meanwhile, similar mean intakes from supplements were
Table 2. Vitamin D status of subjects (n 191) at screening according to
serum 25-hydroxyvitamin D (S-25(OH)D) concentration thresholds
(Numbers and percentages)
East African women
(n 104)
Finnish women
(n 87)
S-25(OH)D (nmol/l) categories n % n %
<30 18 17·3 0 –
30 to <40 21 20·2 3 3·4
40 to <50 19 18·3 5 5·8
50 to <75 39 37·5 46 52·9
75 to <125 7 6·7 29 33·3
≥125 0 – 4 4·6
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Table 3. Characteristics of the participants stratified by intervention group and ethnicity*
(Mean values and standard deviations; n 116)
East African women Finnish women
Dose 0 µg
(n 22)
Dose 10 µg
(n 15)
Dose 20 µg
(n 10)
All
(n 47) P (between
intervention
Dose 0 µg
(n 23)
Dose 10 µg
(n 23)
Dose 20 µg
(n 23)
All
(n 69) P (between
intervention
P (between all
East African and
Mean SD Mean SD Mean SD Mean SD groups) Mean SD Mean SD Mean SD Mean SD groups) Finnish women)
Age (years)† 42·6 9·0 40·5 7·1 39·3 7·0 41·2 8·0 0·523 32·7 7·6 32·8 8·4 32·7 8·4 32·7 8·0 0·994 0·000‡
Height (cm) 163·4 6·1 162·0 5·2 164·0 3·8 163·1 5·3 0·619 164·5 7·0 165·8 5·7 168·2 5·7 166·2 6·2 0·124 0·006‡
Weight (kg)† 78·0 15·2 77·9 9·2 79·1 15·3 78·2 13·3 0·963 62·1 9·5 68·4 14·9 66·4 10·5 65·7 12·0 0·262 0·000‡
BMI (kg/m2)† 29·3 5·8 29·7 3·2 29·3 5·1 29·4 4·8 0·969 23·0 3·5 24·8 4·7 23·5 3·9 23·8 4·0 0·447 0·000‡
Dietary vitamin D intake (µg/d)† 11·2 5·2 12·0 5·8 10·5 4·2 11·3 5·1 0·931 7·7 3·2 8·6 5·1 9·0 3·9 8·4 4·1 0·469 0·002‡
Vitamin D intake from personal supplement
(µg/d)†
10·0 5·6 12·5 14·8 12·2 10·1 11·2 10·1 0·891 5·3 10·5 7·0 9·8 4·8 7·6 5·7 9·3 0·550 0·000‡
Total vitamin D intake from diet and personal
supplement (µg/d)†
21·1 8·4 24·5 17·8 22·6 11·8 22·5 12·6 0·922 13·0 12·3 15·6 10·6 13·8 8·5 14·1 10·5 0·408 0·000‡
Baseline S-25(OH)D (nmol/l) 52·6 12·9 51·6 13·9 52·2 17·8 52·2 14·0 0·979 59·7 16·5 60·8 17·1 61·0 16·8 60·5 16·6 0·962 0·006‡
Baseline serum PTH (pg/ml)†§ 47·0 19·0 50·2 32·8 35·2 24·5 45·2 24·7 0·124 32·4 16·8 29·5 15·3 40·6 17·8 34·1 17·0 0·086 0·021‡
Baseline albumin-corrected Ca (mmol/l) 2·54 0·10 2·53 0·07 2·56 0·11 2·54 0·09 0·565 2·51 0·11 2·49 0·71 2·48 0·07 2·49 0·09 0·546 0·002‡
Baseline serum P (mmol/l) 1·31 0·12 1·23 0·18 1·25 0·11 1·27 0·14 0·233 1·28 0·20 1·30 0·16 1·32 0·15 1·30 0·17 0·750 0·291
PTH, parathyroid hormone.
* Vitamin D intakes calculated from FFQ (mean of baseline and endpoint).
† From non-parametric tests, ANOVA and t-tests (P< 0·05).
‡ Significant differences between East African and Finnish women.
§ n 112 for serum PTH analysis.
Table 4. Daily vitamin D intake (µg/d) from the diet and supplements at baseline*†
(Mean values and standard deviations; n 147)
East African women (n 72) Finnish women (n 75)
All
Supplement
non-users (n 9)
Supplement
users (n 63)
P (between supplement
All
Supplement
non-users (n 40)
Supplement
users (n 35)
P (between supplement P (between all East African
Vitamin D intake (µg/d) Mean SD Mean SD Mean SD non-users and users) Mean SD Mean SD Mean SD non-users and users) and Finnish women)
From diet 11·2 5·8 8·7 7·4 11·6 5·5 0·082 8·4 4·1 7·6 4·1 9·2 4·0 0·063 0·003‡
From supplement 13·0 11·6 – 14·5 11·4 0·000‡ 6·9 12·6 – 14·7 15·1 0·000‡ 0·000‡
Total intake from diet and supplement 24·2 14·3 8·7 7·4 26·0 13·9 0·002‡ 15·2 13·4 7·6 4·1 23·9 15·1 0·000‡ 0·000‡
* Mean vitamin D intakes (µg/d) calculated from baseline FFQ.
† Range from diet: 1·5–29·9 µg/d (East African women); 1·1–18·6 µg/d (Finnish women). Range from supplement: 0·0–60·0 µg/d (East African women); 0·0–57·5 µg/d (Finnish women). Range of total intake: 1·5–89·9 µg/d
(East African women); 1·1–68·2 µg/d (Finnish women).
‡ Significant differences between groups of participants. P values <0·05 from Mann–Whitney U test.
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observed among the voluntary vitamin D supplement users in
both ethnic groups (East African women: 14·5 (SD= 11·4)µg;
Finnish women: 14·7 (SD 15·1) µg, P> 0·05) (Table 4). Participants
using personal vitamin D supplements showed higher total mean
vitamin D intake than those not using personal supplements
(East African women: 26·0 (SD 13·9) v. 8·7 (SD 7·4) µg, P= 0·002;
Finnish women: 23·9 (SD 15·1) v. 7·6 (SD 4·1) µg, P< 0·001)
(Table 4). The proportion of participants attaining the daily
recommended vitamin D intake of 10 µg(2,24) from diet and
supplements was higher in East African women (83%) (n 60)
than in Finnish women (55%) (n 41) (P= 0·003) (data not
shown).
The contributory food sources to the mean daily intake of
vitamin D for both East African women and Finnish women are
presented in Fig. 2. The major source of vitamin D for the two
groups of women was fortiﬁed ﬂuid milk products, with higher
intake in East African women (East African women: 5·2
(SD 4·0) µg; Finnish women: 3·4 (SD= 3·0) µg, P= 0·003). Similar
vitamin D intake from fortiﬁed fat spread and ﬁsh was observed
in both groups (P> 0·05).
Effect of vitamin D supplementation on serum
25-hydroxyvitamin D, serum parathyroid hormone,
serum calcium and serum phosphorus
After the 5-month intervention, the effect of vitamin D3 sup-
plementation on S-25(OH)D among the 116 participants inclu-
ded in the analysis are shown in Fig. 3 (repeated-measures
ANCOVA, adjusted for baseline S-25(OH)D concentration);
compared with placebo, vitamin D supplementation with
both 10- and 20-µg doses signiﬁcantly increased S-25(OH)D
concentration in both ethnic groups. No signiﬁcant differences
were seen between 10- and 20-µg dosages (P> 0·05) in either
of the two ethnic groups. We observed no differences in
the results when we excluded the three East African subjects
who were moved from 20 µg to the placebo group. The results
did not change after adjustment for personal supplement
use, dietary vitamin D intake and BMI. Using a regression
model, there was no signiﬁcant difference in intake-S-25(OH)D
response between women of East African descent and those
of Finnish descent when baseline serum S-25OHD concentra-
tion was included as a covariate (P> 0·3; data not shown).
The mean changes during the study period in the 10-µg
D3 supplement groups for Finnish women and East African
women were +8·5 (+14·1) and +10·0 nmol/l (+19·2%), respec-
tively, and in the 20-µg D3 supplement groups they were
+10·7 (+17·7) and +17·1 nmol/l (+32·7%), respectively. The
mean changes in placebo groups for Finnish women and East
African women were −7·8 (−13·0) and −2·3 nmol/l (−4·4%),
respectively. Between the two groups of women, no signiﬁcant
differences were observed in response to vitamin D3
supplementation (P> 0·05) (Fig. 3). No signiﬁcant effect of
vitamin D3 supplementation on S-PTH, S-Ca or S-Pi was seen in
either East African or Finnish women (P> 0·05) (repeated-
measures ANCOVA, adjusted for baseline S-PTH/S-Ca/S-Pi,
data not shown).
Discussion
This 5-month intervention was the ﬁrst randomised controlled
vitamin D dose–response study in East African and Caucasian
women starting during the winter months, without natural UVB
irradiation. The study demonstrated that supplementation with
10 and 20 µg of vitamin D3 was effective in increasing S-25(OH)D
in both East African and Finnish women, whereas a signiﬁcant
decrease in S-25(OH)D concentrations occurred with placebo
in both ethnic groups. No ethnic differences in S-25(OH)D
5.2 μg
3.4 μg 2.1 μg 1.7 μg 1.2 μg
2.2 μg 1.9 μg 1.9 μg
Finnish women (n 75)
East African women (n 75)
0 2 4 6 8 10 12
Fig. 2. Baseline daily vitamin D intake from dietary sources. Values are mean
vitamin D intakes calculated from baseline FFQ. , Fortified fluid milk
products; , fortified fat spreads; , fish; , others (milk-based foods, main
courses, mushrooms, vitamin D-fortified cheese, bread, juice and mineral
water).
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Fig. 3. Response of serum 25-hydroxyvitamin D (S-25(OH)D) to vitamin D3
supplementation in women of East African (a) and Finnish (b) descent
(adjusted for baseline S-25(OH)D concentrations, repeated-measures
ANCOVA). The time points are at 2·5-month intervals, representing mean
values at each time point; error bars represent standard errors. Comparisons
between intervention groups using contrasts: **P< 0·001 and *P= 0·003 for
the differences compared with placebo; P= 0·105 for East African women and
P= 0·308 for Finnish women for differences between 10- and 20-µg groups in
both ethnic groups. , Placebo; , 10 µg; , 20 µg.
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response to vitamin D3 supplementation between the two ethnic
groups were present.
To date, only a few dose–response vitamin D supplementa-
tion studies have been conducted in ethnically diverse popu-
lations(28–30). Our study found no ethnic differences in
S-25(OH)D response to vitamin D3 supplementation between
East African and Finnish women, consistent with earlier ﬁndings
that the effect of dose on S-25(OH)D is independent of
race(28,29). The two groups of women responded to vitamin D3
supplementation in the same way.
Although our results did not change after adjustment for BMI,
the higher BMI found in East African women might have con-
tributed to their lower mean S-25(OH)D concentrations. Studies
have shown an inverse association between BMI and S-25(OH)D
concentrations(31–34) as large fat mass reduces the bioavail-
ability of synthesised vitamin D deposited in the body fat
compartment(4,35). Negative effects of BMI≥ 25 kg/m2 on
S-25(OH)D have been described among African Americans(32,36).
According to Drincic et al.(34), lower S-25(OH)D concentration
in obese individuals was attributed to volumetric dilution of
ingested or cutaneous vitamin D in the large fat mass. On the
other hand, inconsistent results on the effect of BMI on dose–
response of S-25(OH)D to vitamin D supplementation have
been reported in some studies(37,38). For instance, Grønborg
et al.(39) found no association between body fat and vitamin D
status, and also that body fat had no effect on the response to
vitamin D supplementation. Genetic factors may also inﬂuence
S-25(OH)D circulation(40,41). A probable link between genetic
background and response to vitamin D supplementation or
dietary vitamin D exists; for instance, polymorphisms of the
vitamin D receptor, vitamin D-binding protein or other genetic
determinates of S-25(OH)D have been reported(42,43). A similar
situation with women of African ancestry may exist in our study.
Studies are needed to investigate association between genetic
factors and S-25(OH)D among dark-skinned populations as the
ﬁndings may be different from those among the Caucasian
populations.
In the screening, less than half of the East African women had
sufﬁcient S-25(OH)D concentrations, whereas nine of ten of
their Finnish peers reached the 50 nmol/l as suggested by the
IOM(1) to cover the needs of 97·5% of the population with
regard to bone health. Besides IOM recommendation, the
Endocrine Society suggested S-25(OH)D concentrations above
75 nmol/l for both bone and non-skeletal functions(44), and this
was achieved by 38% of Finnish women but only 7% of East
African women. Similarly to our study, lower S-25(OH)D con-
centrations were observed in Somali women (East Africans)
than in Finnish women in an earlier study carried out in
Finland(12). In other countries besides Finland, high prevalence
of vitamin D deﬁciency (S-25(OH)D< 30 nmol/l) is commonly
reported in Somali subjects (East Africans)(16–18). On the con-
trary, vitamin D status in the general Finnish population has
improved over the years and it is satisfactory(10,45). The S-25
(OH)D concentrations in this study are comparable to those of
the general population. Nonetheless, variation in prevalence of
vitamin D deﬁciency among the European populations has
been described(5). The inexistence of vitamin D deﬁciency and
low insufﬁciency observed in Finnish women of our study may
not represent other European populations, as higher vitamin D
deﬁciencies have been reported(6,17).
Effectiveness of 10- or 20-µg vitamin D3 supplementation has
been observed in studies involving participants with baseline
mean S-25(OH)D concentrations above 50 nmol/l(46,47). Our
results were also consistent with previous RCT among Pakistani
immigrants(19) and Finnish women(48), as we observed an
increase in mean S-25(OH)D concentrations with 10- and 20-µg
dosages of vitamin D3 supplementation in both East African and
Finnish women during the 5-month intervention. The mean
S-25(OH)D concentrations decreased with placebo in both
ethnic groups. The previous studies(19,48) reported greater
increments, which means stronger response to vitamin D3
supplementation, owing to lower basal S-25(OH)D concentra-
tions than in our study. Considering the effect of baseline S-25
(OH)D concentration on response to supplementations, other
RCT(31,48,49) carried out, spanning over 1 year or less, among
subjects with vitamin D insufﬁciency found an increase in the
S-25(OH)D concentration above 50 nmol/l. For instance, in the
studies by Gallagher et al., 10 µg of vitamin D3 increased S-25
(OH)D concentrations by an average of 32·5 nmol/l, whereas a
20-µg dose sufﬁciently increased S-25(OH)D above 50 nmol/l
in 98% and 97·5% of both Caucasian (baseline S-25(OH)D=
39 nmol/l) and African-American women (baseline S-25(OH)
D= 33 nmol/l), respectively(29,31). These suggest that daily
vitamin D supplementation at doses between 10 and 20 µg is
probably adequate to maintain optimal S-25(OH)D concentra-
tions without sunlight exposure during winter. Hence, doses
above 20 µg may not have substantial additional beneﬁts among
persons with sufﬁcient vitamin D concentrations.
Of interest, there was a substantial contribution of dietary
sources to daily vitamin D intake, fortiﬁed ﬂuid milk products
being the major source of vitamin D for both groups of women,
with higher intake in East African women. Although lower
consumption of vitamin-D-fortiﬁed milk was reported among
immigrant women than the native Swedish reference group(6),
milk from camels, cattle or goats is one of the staple diets (also
beverage) in Somalia, and this may explain high milk con-
sumption in our study(50–52). Vitamin D intake from fortiﬁed fat
spreads and ﬁsh was similar in both groups. Similar frequent
consumption of fortiﬁed milk products, as one of the main
dietary sources of vitamin D, has been reported in the general
Finnish population(10). In both East African and Finnish women,
there was similar dietary vitamin D intake among supplement
users and non-users. The mean dietary vitamin D intake in both
groups of women almost reached the 10-µg daily recommended
intake of vitamin D(24). However, the use of supplements
increased the total mean vitamin D intake above the daily
recommendation among the supplement users in both ethnic
groups. Unlike in previous studies(6,12), the rate of supplement
use in our study was higher among the immigrant group.
Nonetheless, higher vitamin D intake may not necessarily
translate to higher S-25(OH)D concentration(12). Despite higher
dietary intake and personal supplementation observed in East
African women, their mean S-25(OH)D concentrations were
lower than in Finnish women.
Our experience of higher vitamin D intake and lower S-25
(OH)D among East African women reﬂects lower endogenous
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vitamin D synthesis from UVB radiation during summer. Such
absence of vitamin D production in the skin emphasises the
relationship between the use of concealing clothes during
summer and lower S-25(OH)D concentrations, especially
among women(4,7). According to Gallagher et al.(29), absorption
and metabolism of vitamin D in African-American and Cauca-
sian women are similar. Hence, the reported lower S-25(OH)D
concentrations in dark-skinned individuals probably occur
owing to decreased formation of vitamin D in the skin(38).
Besides oral vitamin D intake, this result suggests the presence
of other factors (such as BMI and genetic factors) affecting
S-25(OH)D concentrations in these women.
Some factors emerged as limitations against generalisation of
this study’s ﬁndings. First, the baseline mean S-25(OH)D con-
centrations of the two groups of women included in the trial
were quite sufﬁcient (baseline mean S-25(OH)D> 50 nmol/l).
This means that the results may be different in subjects with
vitamin D deﬁciency. Second, the use of personal vitamin D
supplement was not restricted during the intervention, and a
high proportion of personal vitamin D supplementation was
found in East African women. Third, the homogeneity of the
participants with regard to sex (only women) limits the
applicability of the results to men in the population. Fourth,
although the FFQ used to assess the vitamin D intake of all
subjects was piloted among East African women, it was only
validated among Finnish women (Caucasians)(25). Thus, com-
plete vitamin D intake in East African women might have not
been evaluated. In addition, measurement error of the FFQ,
such as over-reporting, might have contributed to the higher
vitamin D intakes among East African women. The reported
high consumption of fortiﬁed ﬂuid milk may be culturally
related to perceived status of milk as important staple diet in
their home country.
One of the strengths of this research lies in the study design
(randomised, placebo-controlled), which allowed for an
objective evaluation of the effects of vitamin D3 doses on
S-25(OH)D. Evaluation of compliance with vitamin D supple-
mentation in this study is considered a strength, and dietary
vitamin D intakes that were assessed at two different points
proved the reliability of our data. Compliance rates with
study supplementation, blood sampling and questionnaires,
including FFQ, in both ethnic groups of women were high. Use
of the participants’ preferred language, including translation
(when necessary), during interviews enhances the quality of
our data. Our ﬁrst of its kind study provides up-to-date data on
vitamin D intake and status in Finnish and East African women
in Finland.
Conclusions
Supplementation with moderate vitamin D3 doses increased the
S-25(OH)D concentrations in both East African and Finnish
women during the 5-month intervention. Our study supports
earlier ﬁndings that ethnicity has no effect on the response of
S-25(OH)D to vitamin D3 supplementation. Future studies
should focus on identifying the factors, other than dietary,
associated with the greatest risk of vitamin D insufﬁciency in
dark-skinned populations.
Acknowledgements
The authors thank all volunteer subjects who participated in the
Marwo-D intervention study. The authors are grateful to the
researchers in the Maamu study for their advice on participants’
recruitment. The authors also thank technician Anu Heiman-
Lindh for laboratory analyses at the University of Helsinki. The
authors acknowledge Oy Verman Ab, Kerava, Finland, for
providing supplements and placebo tablets.
This work was carried out within ODIN WP6 (www.odin-
vitamin D.eu), which is funded by the European Commission
(grant agreement 613977). The funder was not involved in the
design, analysis or writing of this article.
C. L.-A. and K. D. C. are grant holders. F. A. A., S. T. I., T. Ö.,
E. S., E. M. S., M. E. and C. L.-A. were involved in the design of
the study. F. A. A., T. Ö., E. S. and E. M. S. collected the data.
K. D. C. was responsible for the S-25(OH)D analyses at the
University College Cork, Ireland. F. A. A. drafted the manuscript
and performed the statistical analysis with the guidance of
S. T. I. Evaluation of the results and comments on and critical
reviews of the manuscript were carried out by S. T. I., M. E. and
C. L.-A. All co-authors reviewed and approved the ﬁnal draft of
the manuscript.
The authors declare that there are no conﬂicts of interest.
References
1. Ross AC, Taylor CL, Yaktine AL, et al. (editors) (2011) Dietary
Reference Intakes for Calcium and Vitamin D. Institute of
Medicine. Washington, DC: National Academies Press.
2. Nordic Council of Ministers (2014) Nordic Nutrition Recom-
mendations 2012: Integrating Nutrition and Physical Activity,
5th ed. Copenhagen: Nordic Council of Ministers.
3. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al.
(2006) Estimation of optimal serum concentrations of
25-hydroxyvitamin D for multiple health outcomes. Am J Clin
Nutr 84, 18–28.
4. Holick MF (2006) High prevalence of vitamin D inadequacy
and implications for health. Mayo Clin Proc 81, 353–373.
5. Cashman KD, Dowling KG, Škrabáková Z, et al. (2016)
Vitamin D deﬁciency in Europe: pandemic? Am J Clin Nutr
103, 1033–1044.
6. Andersson Å, Björk A, Kristiansson P, et al. (2013) Vitamin D
intake and status in immigrant and native Swedish women:
a study at a primary health care centre located at 60°N
in Sweden. Food Nutr Res 57, 20089.
7. Granlund L, Ramnemark A, Andersson C, et al. (2016)
Prevalence of vitamin D deﬁciency and its association with
nutrition, travelling and clothing habits in an immigrant
population in Northern Sweden. Eur J Clin Nutr 70, 373–379.
8. Holvik K, Meyer HE, Haug E, et al. (2005) Prevalence and
predictors of vitamin D deﬁciency in ﬁve immigrant groups
living in Oslo, Norway: the Oslo Immigrant Health Study. Eur J
Clin Nutr 59, 57–63.
9. Lamberg-Allardt C, Brustad M, Meyer HE, et al. (2013) Vitamin D –
a systematic literature review for the 5th edition of the Nordic
Nutrition Recommendations. Food Nutr Res 57, 22671.
10. Raulio S, Erlund I, Männistö S, et al. (2017) Successful nutrition
policy: improvement of vitamin D intake and status in Finnish
adults over the last decade. Eur J Public Health 27, 268–273.
11. Wändell PE (2013) Population groups in dietary transition.
Food Nutr Res 57, 21668.
Vitamin D in East African and Finnish women 439
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S000711451700397X
Downloaded from https://www.cambridge.org/core. University College Cork, on 14 Mar 2018 at 15:04:38, subject to the Cambridge Core terms of use, available at
12. Islam MZ, Viljakainen HT, Kärkkäinen MU, et al. (2012)
Prevalence of vitamin D deﬁciency and secondary hyper-
parathyroidism during winter in pre-menopausal Bangladeshi
and Somali immigrant and ethnic Finnish women: associa-
tions with forearm bone mineral density. Br J Nutr 107,
277–283.
13. Andersen R, Mølgaard C, Skovgaard LT, et al. (2008) Pakistani
immigrant children and adults in Denmark have severely low
vitamin D status. Eur J Clin Nutr 62, 625–634.
14. Armas LA, Dowell S, Akhter M, et al. (2007) Ultraviolet-B
radiation increases serum 25-hydroxyvitamin D levels: the
effect of UVB dose and skin color. J Am Acad Dermatol 57,
588–593.
15. Libon F, Cavalier E & Nikkels AF (2013) Skin color is relevant
to vitamin D synthesis. Dermatology 227, 250–254.
16. Madar AA, Stene LC & Meyer HE (2009) Vitamin D status
among immigrant mothers from Pakistan, Turkey and Somalia
and their infants attending child health clinics in Norway. Br J
Nutr 101, 1052–1058.
17. Kalliokoski P, Bergqvist Y & Löfvander M (2013) Physical
performance and 25-hydroxyvitamin D: a cross-sectional
study of pregnant Swedish and Somali immigrant women
and new mothers. BMC Pregnancy Childbirth 13, 237.
18. Osmancevic A, Demeke T, Gillstedt M, et al. (2016) Vitamin D
treatment in Somali women living in Sweden – two rando-
mised, placebo-controlled studies. Clin Endocrinol (Oxf) 85,
535–543.
19. Andersen R, Mølgaard C, Skovgaard LT, et al. (2008) Effect of
vitamin D supplementation on bone and vitamin D status
among Pakistani immigrants in Denmark: a randomised
double-blinded placebo-controlled intervention study. Br J
Nutr 100, 197–207.
20. Cashman KD (2014) The vitamin D RDA for African American
adults: higher than that for white persons? Am J Clin Nutr 99,
427–428.
21. Castaneda AE, Rask S, Koponen P, et al. (editors) (2012)
Maahanmuuttajien terveys ja hyvinvointi. Tutkimus venäläis-,
somalialais- ja kurditaustaisista Suomessa (Migrant health and
wellbeing. A study on persons of Russian, Somali and Kurdish
origin in Finland). In Finnish, with English abstract. National
Institute for Health and Welfare (THL), Report 61. Tampere:
Juvenes Print – Suomen Yliopistopaino Oy. http://urn.ﬁ/URN:
ISBN:978-952-245-739-4 (accessed November 2016).
22. Härkänen T (2013) Health 2011 survey: an overview of the
design, missing data and statistical analyses examples.
Department of Health, Functional Capacity and Welfare. The
National Institute for Health and Welfare (THL). http://www.
terveys2011.info/doc/koulutus.pdf (accessed November 2016).
23. Koskinen S, Lundqvist A and Ristiluoma N (editors) (2012)
Terveys, toimintakyky ja hyvinvointi Suomessa 2011 (Health,
functional capacity and welfare in Finland in 2011). In Finnish,
with English abstract. National Institute for Health and
Welfare (THL), Report 68. Tampere: Juvenes Print – Suomen
Yliopistopaino Oy. http://urn.ﬁ/URN:ISBN:951-740-262-7
(accessed November 2016).
24. National Nutrition Council (2014) Suomalaiset ravitse-
mussuositukset – Terveyttä ruoasta (Finnish Nutrition
Recommendations – Health from Food). Tampere: Juvenes
Print (in Finnish).
25. Itkonen ST, Erkkola M, Skaffari E, et al. (2016) Development
and validation of an interview-administered FFQ for assess-
ment of vitamin D and calcium intakes in Finnish women. Br J
Nutr 115, 1100–1107.
26. Cashman KD, Kiely M, Kinsella M, et al. (2013) Evaluation of
Vitamin D Standardization Program protocols for standardizing
serum 25-hydroxyvitamin D data: a case study of the program’s
potential for national nutrition and health surveys. Am J Clin
Nutr 97, 1235–1242.
27. Itkonen S, Skaffari E, Saaristo P, et al. (2016) Effects of vitamin D2-
fortiﬁed bread v. supplementation with vitamin D2 or D3 on
serum 25-hydroxyvitamin D metabolites: an 8-week randomised-
controlled trial in young adult Finnish women. Br J Nutr 115,
1232–1239.
28. Aloia JF, Patel M, Dimaano R, et al. (2008) Vitamin D intake to
attain a desired serum 25‐hydroxyvitamin D concentration.
Am J Clin Nutr 87, 1952–1958.
29. Gallagher JC, Peacock M, Yalamanchili V, et al. (2013) Effects
of vitamin D supplementation in older African American
women. J Clin Endocrinol Metab 98, 1137–1146.
30. Gallagher JC, Jindal PS & Smith LM (2014) Vitamin D sup-
plementation in young White and African American women.
J Bone Miner Res 29, 173–181.
31. Gallagher JC, Sai A, Templin T 2nd, et al. (2012) Dose
response to vitamin D supplementation in postmenopausal
women: a randomized trial. Ann Intern Med 156, 425–437.
32. Gallagher JC, Yalamanchili V & Smith LM (2013) The effect of
vitamin D supplementation on serum 25OHD in thin and
obese women. J Steroid Biochem Mol Biol 136, 195–200.
33. Mazahery H & von Hurst PR (2015) Factors affecting
25-hydroxyvitamin D concentration in response to vitamin D
supplementation. Nutrients 7, 5111–5142.
34. Drincic AT, Armas LA, Van Diest EE, et al. (2012) Volumetric
dilution, rather than sequestration best explains the low vitamin D
status of obesity. Obesity (Silver Spring) 20, 1444–1448.
35. Wortsman J, Matsuoka LY, Chen TC, et al. (2000) Decreased
bioavailability of vitamin D in obesity. Am J Clin Nutr 72,
690–693.
36. Benjamin A, Moriakova A, Akhter N, et al. (2009) Determi-
nants of 25-hydroxyvitamin D levels in African-American and
Caucasian male veterans. Osteoporos Int 20, 1795–1803.
37. Talwar SA, Aloia JF, Pollack S, et al. (2007) Dose response to
vitamin D supplementation among postmenopausal African
American women. Am J Clin Nutr 86, 1657–1662.
38. Zhao LJ, Zhou Y, Bu F, et al. (2012) Factors predicting
vitamin D response variation in non-Hispanic white
postmenopausal women. J Clin Endocrinol Metab 97,
2699–2705.
39. Grønborg IM, Lundby IM, Mølgaard C, et al. (2015) Associa-
tion of body fat and vitamin D status and the effect of body fat
on the response to vitamin D supplementation in Pakistani
immigrants in Denmark. Eur J Clin Nutr 69, 405–407.
40. Wang TJ, Zhang F, Richards JB, et al. (2010) Common genetic
determinants of vitamin D insufﬁciency: a genome-wide
association study. Lancet 376, 180–188.
41. Hansen JG, Tang W, Hootman KC, et al. (2015) Genetic
and environmental factors are associated with serum
25-hydroxyvitamin D concentrations in older African
Americans. J Nutr 145, 799–805.
42. Elnenaei MO, Chandra R, Mangion T, et al. (2011) Genomic
and metabolomic patterns segregate with responses to cal-
cium and vitamin D supplementation. Br J Nutr 105, 71–79.
43. Engelman CD, Meyers KJ, Iyengar SK, et al. (2013) Vitamin D
intake and season modify the effects of the GC and CYP2R1
genes on 25-hydroxyvitamin D concentrations. J Nutr 143,
17–26.
44. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. (2011)
Evaluation, treatment, and prevention of vitamin D deﬁciency:
an Endocrine Society Clinical Practice Guideline. J Clin
Endocrinol Metabol 96, 1911–1930.
45. Jääskeläinen T, Itkonen ST, Lundqvist A, et al. (2017) The
positive impact of general vitamin D food fortiﬁcation
policy on vitamin D status in a representative adult Finnish
440 F. A. Adebayo et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S000711451700397X
Downloaded from https://www.cambridge.org/core. University College Cork, on 14 Mar 2018 at 15:04:38, subject to the Cambridge Core terms of use, available at
population – evidence from an 11-year follow-up based on
standardized 25-hydroxyvitamin D data. Am J Clin Nutr 105,
1512–1520.
46. Cashman KD, Wallace JM, Horigan G, et al. (2009) Estimation
of the dietary requirement for vitamin D in free-living adults
≥64 y of age. Am J Clin Nutr 89, 1366–1374.
47. Nelson ML, Blum JM, Hollis BW, et al. (2009) Supplements of
20 μg/d cholecalciferol optimized serum 25-hydroxyvitamin D
concentrations in 80% of premenopausal women in winter.
J Nutr 139, 540–546.
48. Viljakainen HT, Palssa A, Karkkainen M, et al. (2006) How
much vitamin D3 do the elderly need. J Am Coll Nutr 25,
429–435.
49. Islam MZ, Shamim AA, Viljakainen HT, et al. (2010) Effect of
vitamin D, calcium and multiple micronutrient supplementation
on vitamin D and bone status in Bangladeshi premenopausal
garment factory workers with hypovitaminosis D: a double-
blinded, randomised, placebo-controlled 1-year intervention.
Br J Nutr 104, 241–247.
50. Food and Agriculture Organization of the United Nations
(2005) Somalia nutrition proﬁle – Food and Nutrition Division.
http://www.bvsde.paho.org/texcom/nutricion/som.pdf (accessed
November 2017).
51. Burns C (2004) Effect of migration on food habits of Somali
women living as refugees in Australia. Ecol Food Nutr 43,
213–229.
52. Decker J (2006) Eating habits of members of the Somali
Community: discussion summary. https://snaped.fns.usda.
gov/materials/somali-nutrition-discussion-summary (accessed
November 2017).
Vitamin D in East African and Finnish women 441
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S000711451700397X
Downloaded from https://www.cambridge.org/core. University College Cork, on 14 Mar 2018 at 15:04:38, subject to the Cambridge Core terms of use, available at
